LENTITEK LTDActive

Company number SC633239Private limited companyIncorporated 2019

Key figures

£490,909+128.7%
Net assets 2024/25
+1,274.7%
Average annual growth 2019/20–2024/25
0200 k400 k600 k2019/202020/212021/222022/232023/242024/25

Like most small UK companies, LENTITEK LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0200 k400 k600 k2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand42,808————
Total assets43,47330,048359,969241,891579,259
Total liabilities011,00036,00026,25087,350
Net assets / total equity43,47319,048323,969214,641490,909
Average number of employees01114

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: LENTITEK LTD

Company

LENTITEK LTD is a private limited company registered with Companies House under company number SC633239. It was incorporated on 12 Jun 2019. Its status is active. The registered office is in Edinburgh (EH3). Its nature of business (SIC 2007) is manufacture of basic pharmaceutical products (21100), technical testing and analysis (71200), research and experimental development on biotechnology (72110), other professional, scientific and technical activities n.e.c. (74909).

Accounts

The latest accounts in the database are for 2024/25 (period ending 30 Jun 2025); the company files micro-entity accounts. Net assets were £490,909, up 128.7% on the previous year. Total assets were £579,259 and total liabilities £87,350. The company had an average of 4 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 Mar 2027. The next confirmation statement is due by 20 Aug 2027.